White Paper: Leadership as the Missing Control in the Pharmaceutical Quality System (PQS)

Across the pharmaceutical industry, quality failures rarely occur because procedures are missing. They happen when quality systems are poorly led, inconsistently applied, or treated as a compliance exercise rather than a leadership responsibility.

This white paper explores the critical role of senior leadership in shaping the effectiveness of the Pharmaceutical Quality System (PQS). Drawing on regulatory expectations, inspection trends and real-world observations across GMP organizations, it explains why leadership engagement is the defining factor in quality system maturity and inspection performance.

What you’ll learn

Download this white paper to learn:

• Why PQS failures are often leadership failures rather than technical problems.
• What regulators expect from senior management under ICH Q10 and EU GMP Chapter 1.
• How inspection data highlights leadership accountability in quality system effectiveness.
• The leadership behaviors that drive stronger Quality Management Maturity (QMM).
• Practical ways to strengthen leadership engagement in quality governance.

Who should read this

This white paper is designed for:

• Senior leadership in pharmaceutical and biotech organizations.
• Quality Assurance and Regulatory leaders.
• Manufacturing and operations executives responsible for GMP compliance.
• Organizations seeking to improve inspection readiness and quality maturity.